53 House LLP Invests $11.40 Million in Cigna Group $CI

Key Points

• 53 House LLP has made a new investment of approximately $11.40 million in Cigna Group, acquiring 34,638 shares of the health services provider's stock.
• Cigna Group reported a quarterly earnings per share (EPS) of $7.20, surpassing analysts' estimate of $7.15, with a year-over-year revenue increase of 11.0%.
• The company recently declared a quarterly dividend of $1.51 per share, representing a 2.0% yield with a dividend payout ratio of 32.97%.

53 House LLP purchased a new stake in Cigna Group (NYSE:CI - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 34,638 shares of the health services provider's stock, valued at approximately $11,396,000. Cigna Group comprises approximately 10.1% of 53 House LLP's portfolio, making the stock its 4th largest holding.

A number of other large investors also recently modified their holdings of the company. Brighton Jones LLC raised its position in Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. TD Waterhouse Canada Inc. raised its position in Cigna Group by 29.6% during the 4th quarter. TD Waterhouse Canada Inc. now owns 1,192 shares of the health services provider's stock worth $329,000 after purchasing an additional 272 shares during the last quarter. IHT Wealth Management LLC raised its position in Cigna Group by 28.1% during the 4th quarter. IHT Wealth Management LLC now owns 1,491 shares of the health services provider's stock worth $412,000 after purchasing an additional 327 shares during the last quarter. Kovitz Investment Group Partners LLC raised its position in Cigna Group by 6.5% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 46,052 shares of the health services provider's stock worth $12,717,000 after purchasing an additional 2,820 shares during the last quarter. Finally, Lord Abbett & CO. LLC raised its position in shares of Cigna Group by 10.9% in the 4th quarter. Lord Abbett & CO. LLC now owns 7,117 shares of the health services provider's stock worth $1,965,000 after acquiring an additional 700 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Royal Bank Of Canada reissued an "outperform" rating and issued a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Piper Sandler boosted their target price on Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a research report on Monday, May 5th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $365.00 target price on shares of Cigna Group in a research report on Tuesday. Wells Fargo & Company decreased their target price on Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a research report on Thursday, August 14th. Finally, Cowen reaffirmed a "buy" rating on shares of Cigna Group in a research report on Monday, May 5th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $374.82.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares of the company's stock, valued at $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.70% of the company's stock.

Cigna Group Stock Performance

Cigna Group stock traded down $0.38 during trading on Tuesday, hitting $300.38. The stock had a trading volume of 2,487,036 shares, compared to its average volume of 2,118,207. Cigna Group has a 1 year low of $256.89 and a 1 year high of $370.83. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock's 50 day moving average is $300.40 and its two-hundred day moving average is $311.71. The stock has a market cap of $80.18 billion, a price-to-earnings ratio of 16.40, a price-to-earnings-growth ratio of 0.88 and a beta of 0.47.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the business earned $6.72 earnings per share. Cigna Group's revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group's dividend payout ratio is presently 32.97%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.